News

Clinical Trials Arena on MSN1d
Moderna’s mRNA flu shot outperforms current standard at Phase III
The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.
Experimental Moderna flu shot more effective than approved vaccine, company says
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...
New Scientist1d
Single antiviral shot could offer better protection than flu vaccines
A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...
Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine
RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...
Moderna's mRNA Flu Vaccine Outperforms Standard Shots
Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...
Medscape1d
High-Dose Flu Shot Beats Standard Dose in At-Risk Patients
Researchers conducted a meta-analysis of 16 randomised clinical trials comparing inactivated high-dose (60 µg haemagglutinin antigen load per strain) and standard-dose (15 µg haemagglutinin antigen ...
NBC DFW1d
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
If regulators approve the flu vaccine, the company can then advance the ... The mRNA-1010 jab also demonstrated strong efficacy for each of the major influenza strains in the shot, including A/H1N1, A ...
Medscape4d
New ACIP Supports Previous Universal Flu Vaccination
A recombinant flu vaccine (Flublok) contains no eggs and was recently approved for use in individuals aged 9 years or older ...